Board member Board member since 2021. Born 1976. Bachelor of Pharmacy from Rhodes University. MSc. from University of Witwatersrand and Executive MBA from University of Cambridge. Other appointments: CEO, invoX Pharma Limited, and Independent Board Member, Jamjoom Pharma. Previous assignments: Head Global BD & M&A, Sandoz AG; Group New Business Development Executive, Aspen Pharmacare Holdings; Vice President Global Business Development, Pharmathen SA; International Licensing Executive, Niche Generics (Unichem Laboratories); and Regulatory Affairs, Merck Generics (Mylan). Independent of the company and its executive management. Not independent in relation to the company’s major shareholders. Holdings in KDventures: 64,001 shares.